Form 8K NextCure Inc For: 23 January
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
NextCure Inc (NXTC)
NextCure Inc stock price live, this page displays NASDAQ NXTC stock exchange data. View the NXTC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the NextCure Inc real time stock price chart below.
What Is the NextCure Inc Stock Price Today?
The NextCure Inc stock price today is 11.920.
What Is the Stock Symbol for NextCure Inc?
The stock symbol for NextCure Inc is "NXTC."
What Stock Exchange Does NextCure Inc Trade On?
NextCure Inc is listed and trades on the NASDAQ stock exchange.
Is NextCure Inc a Good Stock to Buy?
Determining whether NextCure Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NXTC quote. (ISIN: US65343E2072)
What Is the NextCure Inc Stock Price Today?
The NextCure Inc stock price today is 11.920.
What Is the Stock Symbol for NextCure Inc?
The stock symbol for NextCure Inc is "NXTC."
What Stock Exchange Does NextCure Inc Trade On?
NextCure Inc is listed and trades on the NASDAQ stock exchange.
Is NextCure Inc a Good Stock to Buy?
Determining whether NextCure Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NXTC quote. (ISIN: US65343E2072)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.040
12.550
52 wk Range
2.688
15.740
NXTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.04012.550
52 wk Range
2.68815.740
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NXTC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
17.667
Upside
+48.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
- Form 8K NextCure Inc For: 23 January
- Investing.com
- Form 424B5 NextCure Inc For: 22 December
- Investing.com
- Form 8K NextCure Inc For: 19 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
NextCure Inc Company Profile
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company’s product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer’s disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
Compare NXTC to Peers and Sector
Metrics to compare | NXTC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNXTCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −4.4x | −0.6x | |
PEG Ratio | −0.14 | 0.15 | 0.00 | |
Price/Book | 1.8x | 4.0x | 2.6x | |
Price / LTM Sales | - | 199.8x | 3.4x | |
Upside (Analyst Target) | 51.0% | 96.2% | 42.0% | |
Fair Value Upside | Unlock | −10.2% | 5.0% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 17.667
(+48.21% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
-3.22 / -0.45
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the NextCure (NXTC) Stock Price Today?
The NextCure stock price today is 11.920
What Stock Exchange Does NextCure Trade On?
NextCure is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for NextCure?
The stock symbol for NextCure is "NXTC."
What Is the NextCure Market Cap?
As of today, NextCure market cap is 41.79M.
What Is NextCure's Earnings Per Share (TTM)?
The NextCure EPS (TTM) is -23.87.
When Is the Next NextCure Earnings Date?
NextCure will release its next earnings report on Nov 05, 2025.
From a Technical Analysis Perspective, Is NXTC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has NextCure Stock Split?
NextCure has split 1 times.
How Many Employees Does NextCure Have?
NextCure has 43 employees.
What is the current trading status of NextCure (NXTC)?
As of Jan 24, 2026, NextCure (NXTC) is trading at a price of 11.920, with a previous close of 12.650. The stock has fluctuated within a day range of 11.040 to 12.550, while its 52-week range spans from 2.688 to 15.740.
What Is NextCure (NXTC) Price Target According to Analysts?
The average 12-month price target for NextCure is USD17.667, with a high estimate of USD20 and a low estimate of USD15. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +48.21% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.